A new two-step method makes more uniform antibody-drug conjugates by attaching cancer drugs at a precise antibody site, ...

A drug candidate created with AI reduced biological age markers across 6 proteomic clocks in a phase 2a trial, suggesting ...

Anthropic says that its new tool can help scientists more quickly uncover and develop new drugs. But FDA approval still takes ...

Neuroscientist Dr. Donna Cross is behind the promising research.

Foundation models will change the way we study the natural, applied and clinical sciences, but only under certain conditions, ...

AI-developed drugs have shown early promise but have not yet been tested in wider clinical trials.

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. Researchers have applied ...

Every few years, drug development goes through a moment where a new technology promises to change everything. Artificial ...

AI could cut preclinical drug R&D costs and timelines by 70%, but its real test is whether it helps deliver safe, effective medicines to patients.

Top US Food and Drug Administration (FDA) officials said the agency is open to novel, “innovative approaches” to the clinical ...